Page last updated: 2024-11-01

nu2058 and Prostatic Neoplasms

nu2058 has been researched along with Prostatic Neoplasms in 1 studies

NU2058: structure in first source

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rigas, AC1
Robson, CN1
Curtin, NJ1

Other Studies

1 other study available for nu2058 and Prostatic Neoplasms

ArticleYear
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.
    Oncogene, 2007, Dec-06, Volume: 26, Issue:55

    Topics: Androgens; Anilides; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-D

2007